U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205289) titled 'Serum Collection Study for Assay Development' on Sept. 25.
Brief Summary: The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Pneumococcal Disease, Invasive
Pneumococcal Disease
Intervention:
BIOLOGICAL: Gamma-PN
Killed whole-cell pneumococcal vaccine
Recruitment Status: RECRUITING
Sponsor: GPN Vaccines
Published by HT Digital Content Services with permission from Health Daily Digest....